Literature DB >> 3163900

Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moiety.

J J Schentag1, L S Welage, J S Williams, J H Wilton, M H Adelman, D Rigan, T H Grasela.   

Abstract

Normal volunteers and patients were studied to determine the relative importance of NMTT and patient risk factors in the production of hypoprothrombinemia. The normal volunteers demonstrated in vivo NMTT production, but the order of magnitude (cefoperazone, moxalactam, and cefotetan in descending order) was different from the usual order of clinical risk. In patients, there was not a NMTT-concentration-versus-effect relationship. Patients who were vitamin K deficient were more sensitive to lower NMTT concentrations than those with normal vitamin K status. In surveillance studies, NMTT-containing antibiotics were nor more frequently associated with hypoprothrombinemia or bleeding than antibiotics that lack this moiety.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163900     DOI: 10.1016/s0002-9610(88)80210-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazole.

Authors:  L S Welage; M T Borin; J H Wilton; L G Hejmanowski; P B Wels; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

2.  Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan.

Authors:  L S Welage; L G Hejmanowski; J H Wilton; C Walawander; D Rigan; J S Williams; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

3.  Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature.

Authors:  ZhuYing Cai; Wei Yang; YingYing He; Qingge Chen; ShiQiang Wang; Xuming Luo; Xiongbiao Wang
Journal:  Drug Saf Case Rep       Date:  2016-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.